Pharmacokinetic (PK) analysis of concurrent administration of enzalutamide (enza) and crizotinib (crizo) in patients with metastatic castration resistant prostate cancer (CRPC) Meeting Abstract


Authors: Tripathi, A.; Supko, J. G.; Gray, K. P.; Melnick, Z.; Taplin, M. E.; Choudhury, A. D.; Pomerantz, M.; Bellmunt, J.; Yu, C.; Sun, Z.; Srinivas, S.; Kantoff, P. W.; Sweeney, C.; Harshman, L. C.
Abstract Title: Pharmacokinetic (PK) analysis of concurrent administration of enzalutamide (enza) and crizotinib (crizo) in patients with metastatic castration resistant prostate cancer (CRPC)
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy284.061
Language: English
ACCESSION: WOS:000459277302034
PROVIDER: wos
DOI: 10.1093/annonc/mdy284.061
Notes: Meeting Abstract: 852P -- Appears on page viii298 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Philip Wayne Kantoff
    197 Kantoff